![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/14/2881906/0/en/Vincerx-Pharma-Reports-First-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/04/26/2870214/0/en/Vincerx-Pharma-Announces-Pricing-of-Underwritten-Public-Offering-of-Common-Stock-and-Warrants.html
https://www.globenewswire.com/news-release/2024/04/08/2859594/0/en/Vincerx-Pharma-Presents-Positive-Preliminary-Phase-1-Data-for-VIP236-and-Updates-on-Pipeline-Progress-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2024.html
https://www.globenewswire.com/news-release/2024/04/01/2855157/0/en/Vincerx-to-Host-Virtual-Investor-Event-Reviewing-Preliminary-Phase-1-VIP236-Data-Presented-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2024.html
https://www.globenewswire.com/news-release/2024/03/29/2854826/0/en/Vincerx-Pharma-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Corporate-Update.html
https://investors.vincerx.com/news-releases/news-release-details/vincerx-present-three-posters-american-association-cancer-0
https://www.globenewswire.com//news-release/2024/01/07/2805016/0/en/Vincerx-Pharma-Announces-Compelling-Clinical-Efficacy-of-Enitociclib-in-Combination-with-Venetoclax-and-Prednisone-in-Lymphoma.html
https://www.globenewswire.com//news-release/2023/11/02/2772449/0/en/Vincerx-Pharma-To-Present-Three-Posters-at-ASH-2023-in-December.html
https://www.fiercebiotech.com/biotech/down-27m-vincerx-starts-pacing-investment-adc-free-cash-lead-cancer-candidates
https://www.globenewswire.com/news-release/2023/05/11/2667280/0/en/Vincerx-Pharma-Reports-First-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html